Analysis of the GSE111177 dataset revealed a significant reduction in VAV2 mRNA levels in patients with PCa following ADT treatment (Fig. 10A), with a positive correlation between AR and VAV2 expression (Fig. 10B). The gene discussed is VAV2; the disease is posterior cortical atrophy.